• Ceramide Metabolism Drives RGNNV Replication via Autophagy M

  2026-06-13

  This study elucidates how red-spotted grouper nervous necrosis virus (RGNNV) manipulates ceramide metabolism to facilitate viral replication in fish cells. By integrating global lipidomics and targeted functional assays, the authors identify ceramides—especially C16-ceramide—as key pro-viral mediators that promote autophagy, offering new mechanistic insights for antiviral strategy development.

• PP 1 (Src Family Tyrosine Kinase Inhibitor): Precision Contr

  2026-06-12

  Explore how PP 1, a potent Src family tyrosine kinase inhibitor, enables unprecedented precision in dissecting immune and oncogenic signaling pathways. This article uniquely bridges advanced mechanistic insight with next-generation assay design, offering researchers actionable guidance grounded in recent machine learning breakthroughs.

• Practical Use of DiI (DiIC18(3)) Plasma Membrane Probe

  2026-06-12

  DiI (DiIC18(3)) enables selective, high-contrast plasma membrane labeling in live and fixed cells, providing robust orange-red fluorescence for applications such as neuronal tracing, cell migration assays, and membrane-specific analyses. It should not be used for aqueous protocols or exclusive intracellular organelle labeling, and strict attention to solvent compatibility and membrane integrity is required for optimal results.

• 3-Bromopyruvate and Cetuximab Co-Treatment Reverses CRC Resi

  2026-06-11

  This study demonstrates that combining 3-bromopyruvate with cetuximab effectively overcomes cetuximab resistance in colorectal cancer by inducing autophagy-dependent ferroptosis and apoptosis. The elucidation of FOXO3a pathway modulation offers new translational avenues for targeting drug-resistant CRC.

• ECL Chemiluminescent Substrate Kit: Hypersensitive Detection

  2026-06-11

  The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) enables ultrasensitive, HRP-based chemiluminescent detection of proteins on nitrocellulose or PVDF membranes. This kit supports low picogram-level sensitivity, long signal duration, and minimal background, making it highly effective for immunoblotting detection of low-abundance proteins.

• TG003: Cdc2-like Kinase Inhibitor for Alternative Splicing R

  2026-06-10

  TG003 is a nanomolar-potency Cdc2-like kinase inhibitor that enables precise modulation of alternative splicing and splice site selection. It is widely used in research on platinum resistance mechanisms and exon-skipping therapies. Benchmark studies highlight its specificity, reproducibility, and utility in both cellular and animal models.

• Structural Insights into TRPM3 Modulation by Neurosteroids a

  2026-06-10

  This study reveals high-resolution cryo-EM structures of the TRPM3 ion channel in complex with neurosteroids and the anticonvulsant primidone, providing a molecular basis for TRPM3 regulation. The findings clarify how disease mutations and pharmacological agents modulate channel gating, offering pathways for developing targeted therapies for pain and neurodevelopmental disorders.

• 25-Hydroxycholesterol Drives Immunosuppressive Macrophage Re

  2026-06-09

  Xiao et al. (2024) uncover how 25-hydroxycholesterol (25HC), produced by CH25H, accumulates in lysosomes of tumor-associated macrophages, activating AMPK and reprogramming metabolism to promote immunosuppression. These findings establish CH25H as a metabolic checkpoint and suggest new strategies for modulating tumor immunity.

• iRhom2 Modulates Odorant Receptor Adaptation in Olfactory Ne

  2026-06-09

  Azzopardi et al. (2024) uncover a specialized role for iRhom2 in olfactory sensory neurons (OSNs), demonstrating its involvement in the regulation and adaptation of odorant receptor gene expression. Their integrative approach reveals an activity-dependent feedback loop linking olfactory stimuli, iRhom2/ADAM17 signaling, and transcriptional changes in the olfactory system.

• MK-2206 dihydrochloride: Applied Strategies in Akt Pathway M

  2026-06-08

  MK-2206 dihydrochloride empowers researchers to dissect PI3K/Akt/mTOR signaling with precision, enabling advanced apoptosis and persistence assays across cancer and infectious disease models. This guide delivers actionable protocols, troubleshooting insights, and applied innovations from the latest host-pathogen research.

• Sulfo-NHS-Biotin: Precision Protein Labeling for Surface Ass

  2026-06-08

  Sulfo-NHS-Biotin stands out for its water solubility and exclusive cell surface specificity, empowering researchers to achieve high-fidelity, amine-selective biotinylation without organic solvents. This guide explores advanced workflows, protocol optimizations, and troubleshooting strategies that maximize the reagent’s potential in proteomics, immunoprecipitation, and interaction mapping.

• O-Propargyl-Puromycin: Bridging Mitochondrial Integrity and

  2026-06-07

  This thought-leadership article explores how O-propargyl-puromycin (OPP) empowers translational researchers to dissect the mechanistic interplay between mitochondrial integrity, protein synthesis, and adaptive immunity. By integrating new mechanistic insights from recent immunology research with practical workflow guidance and a forward-looking perspective, the article advances beyond standard product pages to provide actionable, evidence-based strategies for translational research.

• Cy5 NHS ester(Et): Practical Guide for Biomolecule Labeling

  2026-06-06

  Cy5 NHS ester(Et) enables water-soluble, covalent fluorescent labeling of proteins and other biomolecules by targeting primary amines. It is particularly useful for immunofluorescence, flow cytometry, and microscopy workflows that require high labeling efficiency and minimal background. Ethanol-based protocols and long-term storage of dye solutions are not recommended for this reagent.

• Allosteric PDK4 Inhibitors: A New Avenue for Metabolic Disea

  2026-06-05

  The referenced study identifies a novel class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, with compound 8c demonstrating potent activity in vitro and in vivo. These findings provide a robust scaffold for metabolic disease drug development and reveal new intervention points for conditions such as diabetes, allergy, and cancer.

• Targeting CLK2 to Overcome Platinum Resistance in Ovarian Ca

  2026-06-05

  The referenced study identifies Cdc2-like kinase 2 (CLK2) as a key driver of platinum resistance in ovarian cancer through its phosphorylation of BRCA1 and enhancement of DNA damage repair. These findings open new avenues for alternative splicing modulation and targeted therapy in resistant ovarian tumors.

16404 records 1/1094 page Next 12345 下5页 Last page